Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedetta Del Rio

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancers|June 19, 2024
HER2-Altered Non-Small Cell Lung Cancer: A Journey from Current Approaches to Emerging StrategiesGiorgia Ferrari, Benedetta Del Rio, Silvia Novello, et al.
International Journal of Molecular Sciences|May 27, 2023
Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic StrategiesMassimiliano Cani, Valerio Maria Napoli, Edoardo Garbo, et al.
Cancers|October 14, 2023
Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature ReviewEdoardo Garbo, Benedetta Del Rio, Giorgia Ferrari, et al.
Lung Cancer Management|December 12, 2025
Rucaparib in refractory pleural mesothelioma harboring somatic pathogenic BRCA1 and BRCA2 mutation. A report of two casesLuigi Cerbone, Benedetta Del Rio, Sara Delfanti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2026
Emerging Targeted Therapies for HER2-mutant Non-Small Cell Lung CancerBenedetta Del Rio, Silvia Masini, Camilo Cáceres-Galvis, et al.
Biomedicines|January 21, 2023
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center ExperienceIrene Persano, Massimiliano Cani, Benedetta Del Rio, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancers|June 19, 2024
HER2-Altered Non-Small Cell Lung Cancer: A Journey from Current Approaches to Emerging StrategiesGiorgia Ferrari, Benedetta Del Rio, Silvia Novello, et al.
International Journal of Molecular Sciences|May 27, 2023
Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic StrategiesMassimiliano Cani, Valerio Maria Napoli, Edoardo Garbo, et al.
Cancers|October 14, 2023
Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature ReviewEdoardo Garbo, Benedetta Del Rio, Giorgia Ferrari, et al.
Lung Cancer Management|December 12, 2025
Rucaparib in refractory pleural mesothelioma harboring somatic pathogenic BRCA1 and BRCA2 mutation. A report of two casesLuigi Cerbone, Benedetta Del Rio, Sara Delfanti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2026
Emerging Targeted Therapies for HER2-mutant Non-Small Cell Lung CancerBenedetta Del Rio, Silvia Masini, Camilo Cáceres-Galvis, et al.
Biomedicines|January 21, 2023
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center ExperienceIrene Persano, Massimiliano Cani, Benedetta Del Rio, et al.
Pageof 1